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 The overall quality of medical research remains poor, despite longstanding criticisms. 
 The scientific enterprise is business-like and consistently undervalues its own backbone, 
methodology. 
 Despite great initiatives to improve research quality, progress is modest. 
 Top-down action from journals, funding agencies, universities and governments is needed to 
break the cycle. These actions should give methodology a central place in funding acquisition 
as well as study design, conduct, and reporting. 
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Covid-19 research made it painfully clear that the scandal of poor medical research, as denounced by 
Altman in 1994, persists today. The overall quality of medical research remains poor, despite 
longstanding criticisms. The problems are well known, but the research community fails to properly 
address them. We suggest most problems stem from an underlying paradox: although methodology is 
undeniably the backbone of qualitative and responsible research, science consistently undervalues 
methodology. The focus remains more on the destination (research claims and metrics) than on the 
journey. Notwithstanding, research should serve society more than the reputation of those involved. 
While we notice that many initiatives are being established to improve components of the research 
cycle, these initiatives are too disjointed. The overall system is monolithic and slow to adapt. We assert 
that a top-down action is needed from journals, universities, funders and governments to break the cycle 
and put methodology first. These actions should involve the widespread adoption of registered reports, 
balanced research funding between innovative, incremental and methodological research projects, full 
recognition and demystification of peer review, mandatory statistical review of reports, adherence to 
reporting guidelines, and investment in methodological education and research. Currently, the scientific 
enterprise is doing a major disservice to patients and society. 
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The academic world quickly responded to the covid-19 situation, and produced a staggering amount of 
research publications. Whilst nobody would disagree that we need organized collaborative research 
efforts to study disease prevention, management and treatment, the reality is that large swathes of 
research (including pre-prints and peer-reviewed articles) of covid-19 is of poor quality, and this mirrors 
the quality of medical research in general (see Supplementary Material for examples).1,2 For example, 
more than 230 prediction models have been published for the diagnosis of covid-19 infection or for 
predicting prognosis in infected patients.3 A systematic review and critical appraisal of these models 
found that nearly all models were at high risk of bias due to shortcomings in design, analysis and 
reporting. It was therefore not possible to judge whether the authors’ conclusions on performance were 
trustworthy, casting doubt on whether they are safe to use.3 Another example involves research on the 
treatment effect of hydroxychloroquine for covid-19 patients. Early reports claiming positive effects have 
been severely criticized for multiple serious methodological flaws.4 
 
Poor quality research can result from poor design, conduct, or reporting, and leads to ‘research waste’: it 
has little value for patients and society, and can even be harmful if it forms the basis for making 
decisions.5 The flawed research on hydroxychloroquine at the beginning of the pandemic affected policy, 
jeopardizing access for patients with indicated uses for the product, and hampered recruitment of 
patients in subsequent research.6 Research waste is not confined to covid-19, but has been steadily 
accumulating for decades. In 1994, Doug Altman wrote the provocatively titled article ‘The scandal of 
poor medical research’.7 This paper could have been written today, without changing a single word. 
Despite being repeatedly denounced by multiple scientists,8-17 research waste remains a persistent, 
structural and costly problem resulting from how academia works. We argue that the core problem is a 
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paradox: methodology, the very backbone of science, remains overly trivialized by the scientific 
community that funds, undertakes and reports (pre)clinical research. This paradox is endemic and needs 
to be eradicated. Systemic changes to improve science can only be effective if enforced top-down and 
critically based on the unacceptability of this paradox.  
 
The paradox: science undervalues its own backbone, methodology 
 
The current organization of the scientific enterprise is business-like, with a strong focus on procedures 
and box-ticking to ensure that the system remains operational. This has unfortunate but well known 
consequences, of which we describe six in Table 1: (1) research incentives focus on quantity, rather than 
methodological quality, (2) funders and journals prioritize novelty over incremental and replication 
research, (3) researchers’ agendas are dictated by short-term deadlines, (4) peer review remains 
unacknowledged, (5) methodological illiteracy is still accepted, and (6) transparent and complete 
reporting remains rare. This situation maintains and reinforces dubious methodological practices, 
including poor design and preparation, manipulation of data and analysis procedures, incomplete and 
selective reporting, HARKing (hypothesizing after the results are known), spin, publication bias, salami-
slicing, and reluctance to take corrective action after publication (Table 2). This increases the risk that  
incorrect findings are presented as novel insights, leading to poorly founded opinions that require 
significant effort to be debunked. 
 
In 1949, Luykx wrote “whenever quantitative data play a part in a piece of research, the experimental 
design as well as the statistical analysis cannot receive too much emphasis, before, during and on 
completion of the project”.26 Indeed, to find trustworthy answers to research questions, robust 
methodology plays a fundamental role from study planning to study reporting. We argue that the 
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persisting problem of research waste in science follows from paradoxically undervaluing its own 
backbone.39 As long as methodological quality is not needed to publish papers, get promoted, or acquire 
funding, it remains an easy target for negligence.39 The acceptance of low quality research and 
academia’s focus on output quantity may even lead to an adverse selection, where researchers adhering 
to high methodological standards (hence favoring quality over quantity) can experience negative effects 
on career opportunities.8   
 
We posit that health researchers should have at least rudimentary understanding of research 
methodology and statistics, but should often not conduct these aspects of a study by themselves. Rather, 
it should be commonplace that the methodological aspects of a research study are led by researchers 
with dedicated training and experience for the type of research at hand. It has long been argued that 
quantitative research should involve methodologists or statisticians from conception to reporting, yet 
this remains too uncommon.15,26,40,41 Likewise, applied statisticians should involve clinical experts with 
sufficient knowledge of the clinical problem they are addressing, and have knowledge of the required 
methodology to address the research question, because each problem has its peculiarities that can affect 
study design and subsequent analysis. A stronger focus on methodology also implies that statisticians 
and non-statisticians alike should be educated in terms of statistical thinking (and critical appraisal), not 
just the mechanics or even mindless rituals behind statistical calculations.16 Statistics and methodology 
training should discuss how studies are designed, and how research questions are translated into study 
procedures, data collection processes, and analysis tools.  
 
Failure to uphold methodological standards leads to genuine ethical problems. It is unethical to expose 
humans or animals to any risk or inconvenience on research that is methodologically unsound.36,42 There 
are many examples of how poor methodology may lead to exaggerated and even false claims.36,43,44 
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Poorly conducted studies tarnish the literature with untrustworthy knowledge which eventually may 
harm patients, and are a misuse of public funding.  
 
Initiatives for change towards better methodology and reproducibility 
 
All researchers should undertake efforts to improve medical science. One example is that appropriate 
mentorship of young researchers is an important factor for fostering research integrity,29,45  to help 
educate, set standards and encourage accountability. Over time, many scientists have established 
dedicated initiatives to improve the methodological quality of research (see list of examples in Table 3 
and other literature17,24). We highly welcome and value reproducibility networks, the EQUATOR Network 
focusing on transparent reporting, the Center for Open Science and its activities such as the promotion 
of the registered report system, the DORA statement and Hong Kong principles for research(er) 
evaluation, the STRATOS initiative to provide evidence-based guidance of methodological practices for 
observational research, or the FAIR principles for data sharing. Such initiatives are invaluable to increase 
the sense of urgency among all stakeholders. Examples of their impact are available.24  
 
While important, these initiatives are disjointed and constitute bottom-up changes - typically requiring 
the researcher to stumble across such initiatives before they can embed them in their own research 
practices. Achieving change in this way is difficult, as each individual is part of the scientific environment 
with all its interrelations and interests. This environment is slow to adapt. We therefore believe a 
paradigm shift is needed in which all aspects of trustworthy research are broadly taught, valued, 
enforced, and carried out. This shift should be advanced by top-down action from governments that 
have subsidy rules for the institutions falling under its wings, universities, funders, and journals to break 
the cycle and condemn poor methodology. We are aware that activities of stakeholders are inextricably 
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linked, such that major process changes immediately impact on other chains of the scientific 
environment. We believe that the following actions, if enforced top-down,29 would positively impact on 
the quality of medical research. 
 
Widespread adoption of registered reports 
The Declaration to Improve Biomedical and Health Research recently called for three measures: 
mandatory registration of interests, uptake of registered reports by all journals and funders, and pre-
registration and publication of all publicly funded research on a WHO-affiliated research registry.52 The 
registered report scheme is indeed a valuable approach (Table 3): studies are then evaluated based on 
the research question and the proposed methodology to address this question.2,49 Registered reports can 
be linked with journals, but also with funders in a reproducible research grant model. The funding body 
then has transparency regarding the specific research that is funded, and has a near-guarantee of 
publication (https://www.cos.io/initiatives/registered-reports). This will enforce investigators to include 
research methodologists and statisticians in their projects from the start. The format is also ideal for 
replication studies, where the study design is largely determined by the original study.  
 
Balanced research funding with imperative funding allocation for methodological support 
Research funding should also move away from short-termism and hype, and should have robust 
scientific advancement in mind. There needs to be greater balance regarding the funding of all types of 
research, including incremental and replication research.14,22 It is a crucial aspect of responsible science 
that novel claims are corroborated in new data. In addition, by focusing on (high-risk) novelty of the 
research question, methodology will often play a minor role in the decision to allocate funding and 
perhaps also during eventual study conduct. We therefore contend that methodological quality deserves 
a more prominent role in funding decisions. It should become standard to allocate funding for 
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methodological and statistical support of clinical research, as well as for research focused on applied 
methodology and medical statistics. 
 
Upgrade of peer review to become an explicit and full part of curricula and job descriptions 
Performing qualitative review is as important as conducting and publishing studies. Peer review should 
therefore have defined and accepted quality standards, be addressed in the education of researchers, be 
a full part of researchers’ job descriptions, and be appropriately recognized by academic institutions.  
 
Better methodological review of papers 
Applied journals should attach more importance to methodological review of submitted manuscript, as 
study findings are largely irrelevant if the study is flawed.2,39 For example, journals may employ a team of 
qualified people with different methodological expertise (e.g., statisticians, epidemiologists, information 
specialists/librarians, systematic reviewers). One may think of a staged process, where detailed 
methodological/statistical review is performed once the clinical value of the paper has been confirmed. 
When the editorial board includes a statistician, this person may further select manuscripts that require 
detailed methodological and statistical peer review. 
 
Adherence to reporting guidelines  
Using an appropriate reporting guideline should be mandatory, and adherence should be monitored by 
journals – as a minimum, journals should ensure all accepted articles have an accompanying completed 
reporting guideline checklist (that corresponds to the accepted article) that is checked for completeness 
and accuracy prior to publication. We also strongly discourage the policy, adopted by several journals, to 
put the methods section of a publication in smaller font at the end, because this wrongly suggests that 
results matter and methods are uninteresting. We re-iterate study findings based on flawed design, 
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methodology and analysis are largely meaningless – thus understanding this prior to reading the study 
findings is important in the flow of reading a published article. 
 
Investment in methodological study programs and research projects 
All quantitative studies should (ideally) involve a methodologist or statistician. It has been claimed that 
there is a lack of qualified statisticians as well as a lack of access to them.53 Investment is therefore 
needed to support study programs and research projects in the field of research methods and meta-
research.2 Another route to address a shortage of qualified methodologists/statisticians would simply be 
to conduct fewer studies: this would provide more breathing space to ensure methodological quality of 




Since Altman’s 1994 paper, the problem of poor research has persisted – and arguably deteriorated 
further. It is our view that research quality is not taken seriously enough, damaging the scientific 
reputation of medical research. Science should not be a game in which we collect credits to reach the 
next level of our career. We know that research waste is a multi-stakeholder problem involving 
researchers, institutions, governments, journals, and funding agencies.14,46 Recommendations for 
stakeholders have been issued repeatedly, but change is modest and slow.14,17,24,46 In this way, despite 
being strongly sponsored by public money, the scientific enterprise is doing a major disservice to patients 
and society. Rigorous methodology is critical, and this needs to be imposed top-down without 
compromise. 
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Table 1. Issues resulting from the current organization of science that lead to research waste. 
Problem Description 
Research incentives 
focus on quantity, 
rather than 
methodological quality 
Scientists are rewarded to rapidly churn out publications that are often poorly 
designed or use poor-quality data.
8-12
 Research evaluations also focus on journal 
prestige (e.g., the impact factor), number of citations (the ‘H index’), and the 
amount of attention for a publication (e.g., the Altmetric score). Unfortunately, 
these metrics have only a modest and inconsistent association with quality.
18,19
 
Funders and journals 
prioritize novelty over 
incremental and 
replication research 
Funding calls often focus on innovative (though high risk) ideas, sometimes with an 
guarantee that the project will succeed. Such guarantee may come from (often 
unfunded) preliminary results. Such requirements encourage researchers to run 
before they can walk. Often, funders and journals do not prioritize incremental and 
replication research due to perceived lack of novelty. Yet incremental and 





are dictated by short-
term deadlines 
Researchers are confronted with numerous deadlines related to grant proposals, 
conference submissions, training requirements, and doctoral dissertations. For all of 
these deadlines, it is commonplace to present some study findings. To fulfill this 
demand, methodological quality is often compromised. Examples include premature 
end of patient recruitment, unplanned interim analyses, use of poorly uncleaned 
data, small and poorly conceived studies. Such shortcuts lead to the dissemination 
of misleading or premature results.
12
 
Peer review remains 
unacknowledged 
Peer review is one of the only stages in the scientific process where the quality of 
research plans and findings can be evaluated in detail.
23
 In reality, peer review is 
largely carried without recognition, and the quality of peer review reports varies 
considerably.
24,25
 The popularity of the pre-print approach, in which study reports 
are disseminated prior to being peer reviewed for the sake of openness, is therefore 
likely to backfire, in particular given the recent concerning evolution to accompany 
such reports with a press release. 
Methodological 
illiteracy is still 
accepted 
It is a persisting problem that many researchers know too little about methodology 
and many studies are conducted with no or little involvement of adequately trained 






While such reporting is vital for understanding and reproducibility, systematic 
reviews repeatedly indicate that reporting remains incomplete.
27
 Journals play role 
as well, for example by enforcing strict word limits, encouraging ‘brief reports’, 
discouraging supplementary material, or applying charges per page. 
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Table 2. Practices resulting from prioritizing publication appearance over publication quality. 
Practice Description 
Poor study preparation and 
design 
Many studies are poorly designed and ill-prepared, with an insufficiently 
detailed or inaccessible research protocol (if one exists at all).
10,28
 While 
intervention studies in humans more often have a protocol than other 
studies, the mere presence of a protocol does not automatically imply that all 
research team members adhere to it, or that the study is well designed. Poor 
design problems include issues such as inappropriate control group, selection 
bias, small sample size, and failure to use appropriate statistical tools. 
Data or analysis tweaking (e.g. 
p-hacking) 
Many publications contain results that are not fully honest, by tweaking the 
data or analysis procedures or even data fabrication.
13,29
 A particular 
phenomenon is that of p-hacking, where researches experiment with 
statistical approaches and inclusions/exclusions of participants until a 
statistically significant result is obtained.
30
 
Incomplete reporting Key information needed to understand how a study was carried out and what 
was found is often simply not mentioned in publications.
27
 Poor reporting 
can make results unusable or uninterpretable, which subverts the often hard 
work of setting up and conducting the study. 
Selective reporting Many publications suffer from selective reporting by focusing on the most 
interesting or surprising results.
31
 For example, in publications from clinical 
trials, endpoints that were not prespecified are often added and endpoints 
that were prespecified are left out from presentation without justification.
32
 
Spin The interpretation and conclusions of study results are often too strong even 
after peer review, a phenomenon called ‘spin’.
33
 Spin is also seen in the 
tendency to use more positive words in abstracts, and to use exaggerated 
claims when disseminating research results to (social) media.
34
 This can lead 
to overinterpretation and the spread of exaggerated beliefs that take much 
more time to debunk. 
Publication bias A manuscript that reports on a study with less appealing or ‘negative’ results 
are historically less likely to be submitted for publication and accepted by 
journals than other manuscripts. This is the well-known and long-standing 
problem of publication bias.
35
 This is a major ethical problem, because it 
seriously distorts the evidence base and hence our knowledge on the 
effectiveness of interventions. In addition, study participants of unpublished 
trials (referring to tens of thousands of patients) have been exposed to risk 
and inconvenience for no good reason.
36
 Alongside publication bias, there is 
also the tendency that studies with positive results are more frequently cited 
(‘citation bias’), which may further distort the evidence base.
37
 
HARKing (hypothesizing after 
the results are known) 
HARKing means that parts of a publication (such as the introduction and the 
hypothesis) are written to accommodate the final results.
38
 
Salami-slicing The data resulting from a study are often presented in multiple publications 
that are highly similar. The study results are split into ‘minimal publishable 
units’ beyond what is reasonable. For example, researchers may write 
several papers by simply changing the outcomes or variables of interest for 
each paper. 
Reluctance to take corrective 
action post hoc. 
Published papers frequently contain errors, yet journals are not always eager 
to take corrective action when errors are highlighted.
32
 Incorrect/flawed 
research is often not even highlighted: letters to the editor are not very 
common, and often have strict word limits. Author replies to such letters are 
typically defensive and dismissive. 
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Table 3. Examples of initiatives to improve the methodology and reproducibility of research. 
Topic / initiative Description 
Establishment of 
reproducibility networks and 
research centers 
Reproducibility networks/centers aim to improve the robustness of scientific research by investigating 
how research can be improved, and sharing best practices through trainings and workshops. 
Importantly, these networks aim to collaborate with stakeholders (funders, publishers, academic 
organizations) in order to broadly improve research practices. See www.ukrn.org and www.swissrn.org 
for reproducibility networks in the UK and Switzerland. Examples of reproducibility are QUEST at the 
Berlin Institute of Health (https://www.bihealth.org/en/research/quest-center/) and the Center for 
Reproducible Science at the University of Zurich (http://www.crs.uzh.ch/en.html).  
Lancet series on research 
waste in 2014 
17 recommendations for researchers, academic institutions, scientific journals, funding agencies and 
science regulators were provided.
46
 in 2016, it was noticed that this series had an impact, but rather 
hesitatingly.
46
 For example, with respect to being fully transparent during every stage of research, 
researchers mentioned issues such as lack of time, lack of benefit, and fear of being scooped.  
Hong Kong principles for 
research assessment 
The Hong Kong principles focus on responsible research practices, transparent reporting, open science, 
valuing a diversity of research, and recognizing all contributions to research and scholarly activity.
24
 
Examples of specific initiatives that are consistent with each principle are provided. These principles 
were based on earlier efforts such as DORA (www.sfdora.org). DORA has been signed by about 2000 
organizations and more than 15000 individuals, indicating widespread support among academics. 
EQUATOR network 
(Enhancing the QUAlity and 
Transparency Of health 
Research) 
The EQUATOR Network (www.equator-network.org) hosts a library reporting guidelines for a wide 
range of study designs and clinical research objectives, as well as for preparing study protocols.
47
 These 
guidelines are continuously updated and amended where necessary. There is no excuse for not 
following the most relevant guideline(s) when preparing a manuscript. 
STRATOS (STRengthening 
Analytical Thinking for 
Observational Studies. 
The STRATOS initiative unites methodological experts to prepare guidance documents regarding the 
design and analysis of observational studies (www.stratos-initiative.org). Guidance documents are 
prepared on different levels, in order to reach non-statisticians as well as practicing statisticians. 
Center for Open Science 
(COS) 
COS is a center which mission it is to ‘increase openness, integrity, and reproducibility’ of research 
(cos.io).
48
 COS aims to achieve this through meta-research (study and track the state of science), 
infrastructure (see e.g. the Open Science Foundation, osf.io), training, incentives, and 
collaboration/connectivity. They have referred to their vision as scientific utopia. 
Study registries Study registries make study information publicly available at the start of the study, to improve 
transparency and completeness and allow comparison to resulting publications (e.g., clinicaltrials.gov, 
crd.york.ac.uk/prospero). Registration is widely established for interventional studies, and slowly 
getting more attention for observational studies. Recently, initiatives for animal studies are being taken 
(https://preclinicaltrials.eu/, http://animalresearchregistry.org/).  
Registered reports COS has introduced the registered reports system (https://www.cos.io/our-services/registered-
reports): papers undergo peer review before data collection, based on the research questions and the 
proposed methodology.
49
 If the study is considered to be of high methodological quality, it is 
provisionally accepted for publication if the authors adhere to the methodology as registered. 
Currently 244 journals, including medical journals, accept this system as a publishing format. 
Transparence and Openness 
Promotion (TOP) Committee 
TOP, also under the umbrella of COS, provides guidelines to support journals’ policies for the 





Reusability (FAIR) principles 
FAIR provides guiding principles for data sharing, which is important for transparency and utility of 
research projects.
50
 Hitherto, journals and researchers still show considerable reserve towards data 
sharing.
51
 As long as the focus in academia emphasises quantity rather than quality, there will be 
concern that others will take advantage of the effort of collecting (high quality) data.
46
 Further, privacy 
and intellectual property issues are important additional bottlenecks.  
Methodological/statistical 
reviewing 
Several medical journals recognize the importance of methodological review (e.g., statisticians, 
information specialists/librarians), although the implementation varies widely. Some journals decide on 
an ad hoc basis when statistical input is required, although this decision may itself require statistical 
input. Some journals include statisticians on the editorial board, whilst some journals hire a team of 
statisticians and methodologists. 
Reviewer recognition (e.g. 
Publons) 
Initiatives such as Publons (www.publons.com) aim to increase recognition for doing peer review. Such 
initiatives are a good start, although the question remains what peer reviewers really get out of it.  
Replication grants The Dutch Research Council (www.nwo.nl) offers grants for doing replications studies of ‘cornerstone 
research’ (https://www.nwo.nl/onderzoeksprogrammas/replicatiestudies). 
All mentioned URLs were accessed on May 23
rd
 2021. 
         
